Renal sodium–glucose transport: role in diabetes mellitus and potential clinical implications

This publication has 26 references indexed in Scilit:

• Effects of Intensive Glucose Lowering in Type 2 Diabetes
  New England Journal of Medicine, 2008
• Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
  Diabetes, 2008
• Management of Type 2 Diabetes: Oral Agents, Insulin, and Injectables
  Journal of the American Dietetic Association, 2008
• Inhibitor Binding in the Human Renal Low- and High-Affinity Na+/Glucose Cotransporters
  The Journal of Pharmacology and Experimental Therapeutics, 2008
• Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes
  Journal of Medicinal Chemistry, 2008
• Active sugar transport in health and disease
  Journal of Internal Medicine, 2007
• Sodium-Coupled Glucose Cotransporters Contribute to Hypothalamic Glucose Sensing
  Diabetes, 2006
• Surprising Versatility of Na⁺-Glucose Cotransporters: SLC5
  Physiology, 2004
• Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes
  Diabetes Care, 2004
• Anatomical and developmental patterns of facilitative glucose transporter gene expression in the rat kidney.
  Journal of Clinical Investigation, 1993